CanSino Biologics News and Activities

CanSino Biologics is a company listed under the stock ticker 688185 (CN).

View the org chart displaying its 7 main executives

Most searched biographies at CanSino Biologics

• Xuefeng Yu, Executive Chairman Of The Board, Chief Executive Offic...
• Man Cho, Independent Non-Executive Director
• Xuefeng Ji, Director

Popular executive movements at CanSino Biologics

• Xuefeng Ji has joined the company as Director  (posted on December 1 2025).
• Man Cho has joined the company as Independent Non-Executive Director  (posted on December 1 2025).

Create your alert
to follow the executive moves at CanSino Biologics.

CanSino Biologics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by CanSino Biologics

Social media about CanSino Biologics

• CanSino Biologics on Wikipedia, Google News & Yahoo Finance
• CanSino Biologics on LinkedIn, X (Twitter) & YouTube